SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-24-100339
Filing Date
2024-09-16
Accepted
2024-09-16 21:05:31
Documents
1
Period of Report
2024-09-12

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2424157-2_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2424157-2_4seq1.xml 4 3999
  Complete submission text file 0001104659-24-100339.txt   5550
Mailing Address C/O BAXALTA INCORPORATED 1200 LAKESIDE DRIVE BANNOCKBURN IL 60015
Business Address
ORLOFF JOHN J (Reporting) CIK: 0001643941 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-42270 | Film No.: 241302372

Mailing Address 1000 WINTER ST, SUITE 1200 WALTHAM MA 02451
Business Address 1000 WINTER ST, SUITE 1200 WALTHAM MA 02451 857-271-2954
Zenas BioPharma, Inc. (Issuer) CIK: 0001953926 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)